Evidence map›Paper›PMID 34384765›Full record

ArticleBiophysical journal2021

Investigating the two regimes of fibrin clot lysis: an experimental and computational approach.

Franck Raynaud, Alexandre Rousseau, Daniel Monteyne, David Perez-Morga, Karim Zouaoui Boudjeltia, Bastien Chopard

Open access · hybridAbstract read
In one paragraph

Article in Biophysical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Franck RaynaudDepartment of Computer Science, University of Geneva, Geneva, Switzerland. Electronic address: franck.raynaud@unige.ch.
Alexandre RousseauLaboratoire de Médecine Expérimentale, Medicine Faculty, Université libre de Bruxelles (ULB 222 Unit), ISPPC CHU de Charleroi, Hôpital A. Vésale, Montigny-le-Tilleul, Belgium.
Daniel MonteyneLaboratory of Molecular Parasitology, IBMM, Université libre de Bruxelles, Gosselies, Belgium; Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Gosselies, Belgium.
David Perez-MorgaLaboratory of Molecular Parasitology, IBMM, Université libre de Bruxelles, Gosselies, Belgium; Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Gosselies, Belgium.
Karim Zouaoui BoudjeltiaLaboratoire de Médecine Expérimentale, Medicine Faculty, Université libre de Bruxelles (ULB 222 Unit), ISPPC CHU de Charleroi, Hôpital A. Vésale, Montigny-le-Tilleul, Belgium.
Bastien ChopardDepartment of Computer Science, University of Geneva, Geneva, Switzerland.
Hôpital Civil de Charleroi · BEUniversité Libre de Bruxelles · BEUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been observed in vitro that complete clot lysis is generally preceded by a slow phase of lysis during which the degradation seems to be inefficient. However, this slow regime was merely noticed, but not yet quantitatively discussed. In our experiments, we observed that the lysis ubiquitously occurred in two distinct regimes, a slow and a fast lysis regime. We quantified extensively the duration of these regimes for a wide spectrum of experimental conditions and found that on average, the slow regime lasts longer than the fast one, meaning that during most of the process, the lysis is ineffective. We proposed a computational model in which the properties of the binding of the proteins change during the lysis: first, the biochemical reactions take place at the surface of the fibrin fibers, then in the bulk, resulting in the observed fast lysis regime. This simple hypothesis appeared to be sufficient to reproduce with a great accuracy the lysis profiles obtained experimentally.

Indexed as

FibrinThrombosisFibrinolysisHumansFibrin

Identifiers

PMID34384765
PMCPMC8510862
OpenAlexW3157018711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.